Rodney Young
About Rodney Young
Rodney Young - Professional Title
Rodney Young is currently the Chief Financial Officer at RAPT Therapeutics. He joined the company in December 2019 and has brought with him over 30 years of executive management and corporate finance experience. His extensive background in finance helps guide RAPT Therapeutics through complex financial landscapes.
Rodney Young's Education
Rodney Young earned both an M.B.A. and a B.A. from the University of Chicago. His educational foundation at a prestigious institution has equipped him with robust analytic and strategic skills that have been instrumental throughout his career in various high-level finance roles.
Rodney Young's Experience
Before joining RAPT Therapeutics, Rodney Young served as Chief Financial Officer of Cellerant Therapeutics, Inc. There, he was responsible for accounting and financial management while also playing a key role in shaping corporate strategy. Prior to Cellerant, he was the Chief Financial Officer and Vice President of Finance and Administration at StemCells, Inc. Additionally, his career includes experience as an investment banker at Lehman Brothers and SG Cowen, focusing on financing and merger and acquisition transactions in healthcare, biotechnology, and pharmaceutical sectors.
Rodney Young in Corporate Strategy
At Cellerant Therapeutics, Inc., Rodney Young significantly impacted corporate strategy. He was tasked with crucial financial responsibilities that aligned with the company's strategic objectives, contributing to its overall mission and goals. His role in corporate strategy highlights his strategic thinking and ability to align financial operations with broader corporate objectives.
Rodney Young's Role in Investment Banking
Rodney Young's tenure as an investment banker at Lehman Brothers and SG Cowen provided him with a deep understanding of financing and merger and acquisition transactions. His focus in these roles was in the healthcare, biotechnology, and pharmaceutical sectors, equipping him with specialized industry knowledge that has been beneficial in his subsequent executive roles.